Masahiro Ando

7.3k citations
79 papers · 1.2k · 1 hit paper · h-index 17

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Oncology top 10%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies

Papers in

Masahiro Ando

70 papers receiving 1.2k citations

Masahiro Ando's Hit Papers

First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy 2009 · 371 citations
3710+5+11Years since publication100200300

Peers

Masahiro Ando
Comparison fields: 5 of 89
  • Pulmonary and Respiratory Medicine 568
  • Oncology 344
  • Cellular and Molecular Neuroscience 231
  • Neurology 74
  • Cancer Research 53
Replace Volker Hans Schartinger with:
Volker Hans Schartinger Austria
Jianming Wang China
Han-Soo Kim South Korea
Zheqi Liu China
Robert E. Hynds United Kingdom
Eric P. Sipos United States
Ioan Ştefan Florian Romania
Suganth Suppiah Canada
Chaojun Tang China
Lutz Schmitz Germany
Masahiro Ando relative to Volker Hans Schartinger Austria Volker Hans Schartinger's profile →
Citations per field
00.5×6.1×
Volker Hans Schartinger · 1×
Citations per year

Countries citing papers authored by Masahiro Ando

Since Specialization
Citations

This map shows the geographic impact of Masahiro Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Ando more than expected).

Fields of papers citing papers by Masahiro Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Ando. The network helps show where Masahiro Ando may publish in the future.

Co-authors

The 25 scholars most cited alongside Masahiro Ando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Masahiro Ando Line = papers co-authored together Masahiro Ando links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#Work
1
First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy
Hit paper breakdown →
2009371
2 2009104
3 201865
4 200147
5 201244
6 200330
7 201729
8 201129
9 201728
10 201828
11 201422
12 201720
13 201118
14 202118
15 202018
16 199217
17 202016
18 200816
19 202015
20 201214

About Masahiro Ando

Masahiro Ando is a scholar working on Cellular and Molecular Neuroscience, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Neurology, having authored 79 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hereditary Neurological Disorders (18 papers), Genetic Neurodegenerative Diseases (9 papers), Neurological diseases and metabolism (7 papers), Lung Cancer Research Studies (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Lung Cancer Treatments and Mutations (7 papers), RNA regulation and disease (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (568 citations), Oncology (344 citations), Cellular and Molecular Neuroscience (231 citations), Neurology (74 citations) and Cancer Research (53 citations). Masahiro Ando has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Akihiko Gemma, Koichi Hagiwara, Hiroshi Takashima, Kunihiko Kobayashi, Tomoaki Tanaka, Hitoshi Miyazawa, Akira Inoue, Kenji Ikebuchi, Akiko Yoshimura and Iwao Mikami. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Neurology, Journal of Neurology, Annals of Clinical and Translational Neurology and Journal of Neurology Neurosurgery & Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact